From applied microbiology to biotechnology: science, medicine and industrial renewal

In the late 1970s politicians and civil servants were acutely aware of the chronic decline of the manufacturing sector as a source of employment in Britain. At a time of fear of mass unemployment, sources of new work were urgently sought. Biotechnology had been promoted by visionaries since the early twentieth century. With oil prices soaring, its potential to produce substitutes for petroleum derivatives seemed newly attractive. At the beginning of 1976, John Bu'Lock at Manchester brought the attention of the new President of the Royal Society, Lord Todd, to the developments in enzyme and fermentation technologies. Both the Society and government began to take biotechnology seriously. In 1979 the Society organized a groundbreaking meeting, 'New horizons in industrial microbiology'. In parallel, John Ashworth, the chief scientist of the government think-tank the Central Policy Review Staff, prompted by American developments in genetic engineering, its commercial exploitation and regional development, led thinking among government officials. The Spinks enquiry into biotechnology was consequently formed in 1979 as a collaborative enterprise of the Advisory Council for Applied Research and Development, the Advisory Board for the Research Councils and the Royal Society. The recommendations for far-reaching collaboration between research councils, government and industry were not fully implemented. However, even the limited implementation led to new models of science that would be significant in the emergence of a reconstruction of science.